Contraceptive Drugs Market Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Clinics, Online Channel, Public Channel and NGOs, and Others), and Region 2024-2032
The global contraceptive drugs market size reached US$ 15.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.
Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.
Contraceptive Drugs Market Trends:
One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women’s health, and sexual wellness are positively augmenting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, age group and distribution channel.
Breakup by Product:
Oral Contraceptive Pills
Injectable Contraceptives
Topical Contraceptives
Breakup by Age Group:
15–24 years
25–34 years
35–44 years
Above 44 years
Breakup by Distribution Channel:
Retail Pharmacy
Hospital Pharmacy
Clinics
Online Channel
Public Channel and NGOs
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.
Key Questions Answered in This Report
1. What was the size of the global contraceptive drugs market in 2023?
2. What is the expected growth rate of the global contraceptive drugs market during 2024-2032?
3. What are the key factors driving the global contraceptive drugs market?
4. What has been the impact of COVID-19 on the global contraceptive drugs market?
5. What is the breakup of the global contraceptive drugs market based on the product?
6. What is the breakup of the global contraceptive drugs market based on the age group?
7. What is the breakup of the global contraceptive drugs market based on the distribution channel?
8. What are the key regions in the global contraceptive drugs market?
9. Who are the key players/companies in the global contraceptive drugs market?
Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.
Contraceptive Drugs Market Trends:
One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women’s health, and sexual wellness are positively augmenting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, age group and distribution channel.
Breakup by Product:
Oral Contraceptive Pills
Injectable Contraceptives
Topical Contraceptives
Breakup by Age Group:
15–24 years
25–34 years
35–44 years
Above 44 years
Breakup by Distribution Channel:
Retail Pharmacy
Hospital Pharmacy
Clinics
Online Channel
Public Channel and NGOs
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.
Key Questions Answered in This Report
1. What was the size of the global contraceptive drugs market in 2023?
2. What is the expected growth rate of the global contraceptive drugs market during 2024-2032?
3. What are the key factors driving the global contraceptive drugs market?
4. What has been the impact of COVID-19 on the global contraceptive drugs market?
5. What is the breakup of the global contraceptive drugs market based on the product?
6. What is the breakup of the global contraceptive drugs market based on the age group?
7. What is the breakup of the global contraceptive drugs market based on the distribution channel?
8. What are the key regions in the global contraceptive drugs market?
9. Who are the key players/companies in the global contraceptive drugs market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CONTRACEPTIVE DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Oral Contraceptive Pills
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Injectable Contraceptives
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Topical Contraceptives
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY AGE GROUP
7.1 15–24 years
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 25–34 years
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 35–44 years
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Above 44 years
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Retail Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospital Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Online Channel
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Public Channel and NGOs
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Afaxys Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Agile Therapeutics
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Amneal Pharmaceuticals Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Bayer AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Johnson & Johnson
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Mithra Pharmaceuticals SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Viatris Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CONTRACEPTIVE DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Oral Contraceptive Pills
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Injectable Contraceptives
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Topical Contraceptives
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY AGE GROUP
7.1 15–24 years
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 25–34 years
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 35–44 years
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Above 44 years
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Retail Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospital Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Online Channel
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Public Channel and NGOs
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Afaxys Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Agile Therapeutics
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Amneal Pharmaceuticals Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Bayer AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Johnson & Johnson
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Mithra Pharmaceuticals SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Viatris Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
LIST OF TABLES
Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Contraceptive Drugs Market: Competitive Structure
Table 7: Global: Contraceptive Drugs Market: Key Players
Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Contraceptive Drugs Market: Competitive Structure
Table 7: Global: Contraceptive Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2023
Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2023
Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Contraceptive Drugs (15–24 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Contraceptive Drugs (15–24 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Contraceptive Drugs (25–34 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Contraceptive Drugs (25–34 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Contraceptive Drugs (35–44 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Contraceptive Drugs (35–44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2023
Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis
Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2023
Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2023
Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Contraceptive Drugs (15–24 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Contraceptive Drugs (15–24 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Contraceptive Drugs (25–34 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Contraceptive Drugs (25–34 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Contraceptive Drugs (35–44 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Contraceptive Drugs (35–44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2023
Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis
